Musaffa Logo

Our certifications

Independent proof that every stock and portfolio meets halal standards.

How we screen every stock
METHODOLOGY

How we screen every stock

Our 5-step halal methodology, in 90 seconds.

Nunzia Pharmaceutical Corp

Nunzia Pharmaceutical Corp. Stock Analysis NUNZ

United States Consumer Staples Nano Cap
Nunzia Pharmaceutical Corp. engages in the manufacture and sales of drugs. The company is headquartered in Long Beach, California. The firm focuses on development and delivery of pharmaceutical and nutraceutical-based therapies for the behavioral symptoms of Autistic Spectrum of Disorders (ASDs) and related conditions, such as Fragile X syndrome, as well as common anxiety-based disorders. The firm has developed NUNZIA, which is a combination of 16 vitamins, minerals and herbs which directly focuses and targets the hippocampus area of the brain, where all anxiety-based disorders originate.
Read More

Nunzia Pharmaceutical Corp (NUNZ) Chart

Key Statistics of Nunzia Pharmaceutical Corp (NUNZ)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$0.00$0.00

Today's Open

$0.00

Volume

1000.00

P/E Ratio (TTM)

-

52 Week Range

$0$0.00

Market Cap

40.00K

Avg. Volume

3584.00

Dividend Yield

-

Financial Metrics & Statements of Nunzia Pharmaceutical Corp (NUNZ)

FAQ's for Nunzia Pharmaceutical Corp (NUNZ)

  • According to Musaffa’s Shariah screening methodology, Nunzia Pharmaceutical Corp (NUNZ) is currently classified as NOT COVERED as of June 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.
  • A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Nunzia Pharmaceutical Corp using these criteria to determine its compliance status.
  • Muslim investors may consider investing in Nunzia Pharmaceutical Corp if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
  • Musaffa determines the Shariah status of Nunzia Pharmaceutical Corp by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
  • The Shariah compliance status of Nunzia Pharmaceutical Corp may be updated periodically when new financial statements, earnings reports, or business activity information become available.
  • Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
  • You can check the latest Shariah compliance status of Nunzia Pharmaceutical Corp on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Disclaimer

The content provided on this website is intended solely for informational and educational purposes. Musaffa is a technology, data, education, and research company. We are not licensed financial service provider by the authorized relevant financial service regulator in India or any other regulatory government body, and we do not offer or facilitate any trading, brokerage, investment, or financial advisory services. We do not deliberately target an audience seeking financial services.

By accessing this website, you acknowledge and confirm that you are seeking information relating to Musaffa of your own accord, and that there has been no form of solicitation, advertisement, or inducement by Musaffa or its members. Musaffa shall not be liable for the consequences of any action taken by relying on the material or information provided on this website. The contents of this website are the intellectual property of Musaffa.